RCEL250117P22500
- 0.00
- 0.000.00%
Avita Medical Newsroom
This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
FDA Approves AVITA Medical's RECELL GO Mini For Smaller Wounds
Cantor Fitzgerald Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $21
Avita Medical Price Target Maintained With a $21.00/Share by Cantor Fitzgerald
Cantor Fitzgerald Bullish on Avita Medical After FDA Approval for RECELL GO Mini
D. Boral Capital Initiates Avita Medical(RCEL.US) With Buy Rating, Announces Target Price $25
Avita Medical Initiated With a Buy at D. Boral Capital
Express News | D. Boral Capital Initiates Coverage On AVITA Medical With Buy Rating, Announces Price Target of $25
AVITA Medical Analyst Ratings
Biggest Stock Movers Tuesday: X, CYTK, and More
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $15
AVITA Medical Gets FDA Approval for Recell Go Mini to Treat Smaller Wounds
AVITA Medical Announces FDA Approval of RECELL GO Mini, Optimizing Treatment for Smaller Wounds
Express News | AVITA Medical Announces FDA Approval of Recell Go Mini, Optimizing Treatment for Smaller Wounds
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $20
Lake Street Gives a Buy Rating to Avita Medical (RCEL)
AVITA Medical Gets FDA Clearance for Wound Treatment; Shares Rise After Hours
Express News | AVITA Medical Inc - to Develop Clinical Data for Cohealyx in Early 2025
Express News | AVITA Medical Announces FDA 510(K) Clearance for Cohealyx, Expanding Its Addressable Market
Why Is AVITA Medical Inc. (RCEL) Among the Best Cosmetic Surgery and Aesthetics Stocks to Invest In Now?